每年的2月4日是世界癌症日,訂立在這天主要是提高全球對於癌症的認識,促進癌症預防、檢測和治療的努力。癌症作為一種嚴重的疾病,對世界各地的人們造成巨大的健康威脅。然而隨著科學技術的發展,我們有了更多的工具來對抗癌症。
在癌症的研究和診斷中,生物標記(biomarkers)扮演重要的角色。生物標記是能夠指示或預測特定生物狀態的物質,如某種疾病的存在或發生。透過檢測和分析這些生物標記,我們能夠提前發現疾病,進行更準確的診斷,並選擇更有效的治療方法。
以下將整理各種癌症相關的生物標記物:
癌症轉移之生物標記
癌症轉移是指從原發腫瘤轉移到遠處組織或器官,此過程可以說確定癌症發病率的一個重要因素之一,也是癌症惡性的特點。
Immunohistochemistry(IHC)在預測癌症、腫瘤轉移的判讀對於早期個人化治療癌症非常重要。因此準確的癌症轉移生物標記能夠幫助檢測轉移的早期階段、癌症轉移的首選部位以及癌症復發的風險。
|
||
|
||
|
||
|
||
|
肺癌生物標記
肺癌是全球癌症死亡的主要原因之一,大約佔整體的三分之一。肺癌也分成不同類型以及其細胞來源,包含腺癌、鱗狀細胞癌和大細胞癌。對於檢測這些不同類型的肺癌,可選擇用於檢測肺癌特異性生物標記物的抗體。
Marker | Localization | Recommended IHC antibody |
Nuclear and Cytoplasm | – | |
Cell Membrane | ||
Cell Membrane | ||
Secreted protein within the extracellular space | ||
Nuclear | ||
Cell Membrane | ||
Secreted Protein and Cell Membrane | ||
Cytoplasm | ||
Nuclear | ||
Nuclear | ||
Mitochondrion Outer Membrane, Peroxisome Membrane. Microsome Membrane, Endoplasmic Reticulum Membrane. |
乳癌生物標記
IHC 是乳癌診斷和乳癌病理研究中常用的方法,透過特定的生物標記可以確認乳癌不同的類型,例如:原位癌或浸潤性癌、區分正常乳腺細胞類型(luminal, basal and myoepithelial)、增殖和疾病進展。
Marker |
Localization |
Recommended
IHC antibody |
Nuclear |
||
Nuclear |
||
Cytoplasmic, Nuclear, and Strongly
in the cell membrane |
||
Cytoplasm and Strong Nuclear |
||
Nuclear Signal |
||
Cytoplasm and Strong Nuclear |
||
Cytoplasm |
||
Cytoplasm |
||
Nuclear |
||
Nuclear |
||
Cytoplasm |
||
Cell membrane |
||
Nuclear signal |
||
Nuclear signal |
||
Cytoplasm and Cell Membrane |
||
Cytoplasm |
||
Cell junctions |
||
Cytoplasm |
||
Cytoplasm |
||
Cytoplasm and Cell Membrane |
||
Cytoplasm |
||
Emerging breast cancer biomarkers |
||
Emerging breast cancer biomarkers |
大腸直腸癌生物標記物
大腸直腸癌是全球常見的惡性腫瘤之一,為了更準確的診斷和治療大腸直腸癌,尋找並研究與相關的生物標記非常重要,以協助早期檢測、確認病變類型及惡性程度。
Marker | Localization | Recommended IHC antibody |
Cytoplasmic and Nuclear | ||
Intestine, Secreted into the inner and outer mucus layers | ||
Microsome Membrane and Endoplasmic Reticulum | ||
Cell Membrane | ||
Cell Membrane | ||
Secreted and Cell Membrane | ||
Secreted Protein | ||
Cytoplasm and Strong Nuclear | ||
Nuclear | ||
Secreted Protein | ||
Nuclear and Cytoplasm | ||
Nuclear | ||
Cell Membrane | ||
Cytoplasm | ||
Cytoplasm | ||
Cytoplasm | ||
Emerging Colorectal Cancer Biomarkers |
前列腺癌生物標記
前列腺癌是全球男性第二常見的癌症。由於用於前列腺IHC診斷的生物標記其精準度和準確性仍存在爭議,目前仍正在尋找替代的特異性和敏感的前列腺癌生物標記物來改善結果。
Marker | Localization | Recommended IHC antibody |
Cytoplasmic and Extracellular | ||
Cytoplasmic | ||
Membrane | ||
Cytoplasmic and Cell Membrane | ||
Secreted, Cytoplasmic and Cell Membrane | ||
Nuclear | ||
Nuclear | ||
Nuclear and Cytoplasmic | ||
Nuclear | ||
Nuclear | ||
Nuclear | ||
Cytoplasmic and Secreted | ||
Nuclear | ||
Nuclear and Cytoplasmic in some cancers | ||
Cytoplasmic | ||
Cytoplasmic | ||
Cytoplasmic and Secreted | ||
Emerging prostate cancer biomarkers | ||
Emerging prostate cancer biomarkers |
卵巢癌生物標記
卵巢癌是女性婦科癌症死亡的主要原因,此疾病的高死亡率主要是由於疾病診斷已處於晚期,對於治療成功率相對較低。因此若有適合卵巢癌診斷和預後生物標記,就能夠預測早期卵巢癌的存在、疾病狀態、分期和相關治療效果的能力,可改變卵巢癌的檢測和治療。
Marker |
Localization |
Recommended
IHC antibody |
Nuclear |
||
Strong Membranous
Staining |
||
Nuclear |
||
Nuclear |
||
Nuclear |
||
Nuclear and
cytoplasmic |
||
Nuclear stain.
Cytoplasmic staining alone is considered negative for ovarian cancer. |
||
Nuclear |
||
Nuclear, Perinuclear
and Membranous |
||
Secreted |
||
Cell Membrane |
||
Secreted |
||
Secreted |
||
Cytoplasmic |
||
Cytoplasmic |
||
Cytoplasmic |
||
Cytoplasmic |
||
Nuclear |
||
Nuclear |
||
Emerging ovarian
cancer biomarkers |
||
Emerging ovarian
cancer biomarkers |
胰臟癌生物標記
胰臟癌是全球第七大癌症死亡原因之一,死亡率與發病率一致,代表著此癌症類型有著預後不良。透過不斷發現和驗證新的腫瘤相關生物標記以及開發有效的IHC組合,病理學家可以區分不同類型的胰臟癌,並將胰臟癌與其他繼發性轉移癌區分開來。
Marker |
Localization |
Recommended
IHC antibody |
Nuclear and Cytoplasmic |
||
Nuclear and Cytoplasmic |
||
Membranous and Cytoplasmic |
||
Extracellular, Cell
Membrane and Punctate cytoplasmic staining |
||
Nuclear staining
in normal cells with loss of nuclear staining in malignancy |
||
Cytoplasmic and Nuceloplasmic |
||
Secreted and Cell
Membranous |
||
Cytoplasmic |
||
Nuclear |
||
Cell membrane |
||
Cell membrane |
||
Secreted and Cell
Membrane |
||
Nuclear |
||
Cell Membrane |
||
Nuclear |
||
Cytoplasmic |
||
Cell membrane |
||
Cytoplasmic |
||
Nuclear |
||
Secreted |
||
Secreted |
||
Emerging
pancreatic cancer biomarkers |
||
Emerging
pancreatic cancer biomarkers |